ABCL

#2371
AbCellera Biologics Inc. Common Shares
3.76 USD
+2.73%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
3.76
3.76
Jahresspanne
1.94
6.52
Tagesänderung
+2.73%
Monatliche Änderung
+6.52%
6 month change
-33.69%
Jahresänderung
+55.37%
Vorheriger Schlusskurs
3.66
Eröffnung
3.76
Bid
Ask
Tief
3.76
High
3.76
Volumen
45
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
Gewinn- und Verlustrechnung Bilanz Cashflow
Wert 20212022202320242025 TTM

AbCellera Biologics Inc

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Nachrichten